Gennex Laboratories Ltd
₹0.00▲ +0.00 (+0.00%)
531739·NSE·Healthcare
Market Cap
220.64 Cr
PE Ratio
10.60
Volume
—
Day High - Low
—
52W High-Low
17.25 - 7.05
₹0.00▲ +0.00 (+0.00%)
Market Cap220.64 Cr
PE Ratio10.60
Volume—
Day High - Low—
52W High-Low17.25 - 7.05
Gennex Laboratories Ltd (531739): company summary
Gennex Laboratories Ltd (531739) is a micro-cap Healthcare company valued at ₹221 crore operating in Pharmaceuticals on the NSE and BSE.
Gennex Laboratories Ltd (531739) is a micro-cap Healthcare company valued at ₹221 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been growing strongly at 37.9% a year over three years; profit grew 61.3% a year, ahead of revenue — margins are expanding. Return on equity is 9.3%.
- Valuation multiples
- The stock trades at 10.6 times earnings, a discount to the Healthcare median of 32.5, 0.99 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
6.4/10
Fair
Fair Value
Sign in to see
ROE
9.25%
Average
P/E
10.60x
Cheap
Debt / Equity
0.36
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Fair
Price performance
52W₹7.05
₹17.25
DocStoX take
Supported by growth (10.0) and valuation (8.1), but held back by quality (3.7). Scored on 4 of 5 measures.
DocStoX score
Medium confidence6.4
/10
Fair
Quality
Modest
ROE 9.3%
Valuation
Cheap
P/E 10.6×
Growth
Strong
Revenue +23.6% 5Y CAGR
Risk
Elevated
D/E 0.36
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹221 Cr
52W High / Low
₹17 / ₹7
Dividend Yield
0.00%
Promoter Holding
23.63%
EPS (TTM)
₹0.76
Book Value
₹9.16
Key highlights
- Profit compounding 39% a year
- Profitable in all of the last 5 years
- Undemanding at 11× earnings
- Small ₹221 cr company — thinner liquidity
4 Positives1 Watchout
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Gennex Laboratories Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Gennex Laboratories Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LAPOLLO HOSPITALS ENTER. LZYDUS LIFESCIENCES LTDCIPLA LTDLAURUS LABS LIMITEDMAX HEALTHCARE INS LTDAUROBINDO PHARMA LTDDR. REDDY S LABORATORIESLUPIN LIMITEDMANKIND PHARMA LIMITED
Compare Gennex Laboratories Ltd with peers
Related tools & concepts
Value Gennex Laboratories Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing